Company

SUTRO BIOPHARMA, INC. (STRO)

Standardized SEC financial data for SUTRO BIOPHARMA, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001382101 · NASDAQ · Biological Products, (No Diagnostic Substances).

Operating margin

-154.5%

Net margin

-186.4%

Revenue growth (YoY)

65.2%

Return on equity

144.3%

Free cash flow

-$178.8M

Debt / equity

-0.06×

Current ratio

2.01×

EPS (diluted)

$-22.49

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$42.7M	$61.9M	$67.8M	$153.7M	$62.0M	$102.5M
R&D expense	$77.0M	$104.4M	$137.2M	$180.4M	$252.0M	$166.4M
SG&A expense	$36.8M	$56.0M	$59.5M	$62.6M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$207.0M	$31.3M	$48.1M	$70.1M	$191.2M	$59.0M
Total current assets	$378.2M	$218.5M	$353.2M	$421.5M	$343.3M	$150.9M
Property, plant & equipment	$12.9M	$22.6M	$24.6M	$21.9M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$67.8M	-$81.7M	$3.5M	-$111.6M	-$191.5M	-$177.2M
Investing cash flow	$604K	-$97.3M	-$35.0M	-$3.9M	$218.5M	$45.0M
Financing cash flow	$269.2M	$3.3M	$48.3M	$137.6M

Get STRO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/STRO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/STRO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View STRO filings on SEC EDGAR →